Literature DB >> 19088736

A new function for the RNA-editing enzyme ADAR1.

Hisashi Iizasa1, Kazuko Nishikura.   

Abstract

ADAR1 catalyzes the deamination of adenosine to inosine in double-stranded RNA. This RNA-editing enzyme is now shown to be involved in hematopoiesis, where it acts to suppress interferon signaling and to block premature apoptosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19088736      PMCID: PMC2945685          DOI: 10.1038/ni0109-16

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  12 in total

1.  Redirection of silencing targets by adenosine-to-inosine editing of miRNAs.

Authors:  Yukio Kawahara; Boris Zinshteyn; Praveen Sethupathy; Hisashi Iizasa; Artemis G Hatzigeorgiou; Kazuko Nishikura
Journal:  Science       Date:  2007-02-23       Impact factor: 47.728

2.  ADAR1 interacts with NF90 through double-stranded RNA and regulates NF90-mediated gene expression independently of RNA editing.

Authors:  Yongzhan Nie; Li Ding; Peter N Kao; Robert Braun; Jing-Hua Yang
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

Review 3.  Editor meets silencer: crosstalk between RNA editing and RNA interference.

Authors:  Kazuko Nishikura
Journal:  Nat Rev Mol Cell Biol       Date:  2006-12       Impact factor: 94.444

4.  Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules.

Authors:  Zhichao Wang; Myoung Kwon Choi; Tatsuma Ban; Hideyuki Yanai; Hideo Negishi; Yan Lu; Tomohiko Tamura; Akinori Takaoka; Kazuko Nishikura; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-28       Impact factor: 11.205

5.  Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1.

Authors:  Jochen C Hartner; Carolin Schmittwolf; Andreas Kispert; Albrecht M Müller; Miyoko Higuchi; Peter H Seeburg
Journal:  J Biol Chem       Date:  2003-11-12       Impact factor: 5.157

6.  Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene.

Authors:  Qingde Wang; Mana Miyakoda; Weidong Yang; Jaspal Khillan; David L Stachura; Mitchell J Weiss; Kazuko Nishikura
Journal:  J Biol Chem       Date:  2003-11-12       Impact factor: 5.157

7.  Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome.

Authors:  Alekos Athanasiadis; Alexander Rich; Stefan Maas
Journal:  PLoS Biol       Date:  2004-11-09       Impact factor: 8.029

8.  Systematic identification of abundant A-to-I editing sites in the human transcriptome.

Authors:  Erez Y Levanon; Eli Eisenberg; Rodrigo Yelin; Sergey Nemzer; Martina Hallegger; Ronen Shemesh; Zipora Y Fligelman; Avi Shoshan; Sarah R Pollock; Dan Sztybel; Moshe Olshansky; Gideon Rechavi; Michael F Jantsch
Journal:  Nat Biotechnol       Date:  2004-07-18       Impact factor: 54.908

9.  Hematopoiesis: an evolving paradigm for stem cell biology.

Authors:  Stuart H Orkin; Leonard I Zon
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

10.  ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling.

Authors:  Jochen C Hartner; Carl R Walkley; Jun Lu; Stuart H Orkin
Journal:  Nat Immunol       Date:  2008-12-07       Impact factor: 25.606

View more
  11 in total

1.  ADAR1 deaminase contributes to scheduled skeletal myogenesis progression via stage-specific functions.

Authors:  C-L Hsieh; H Liu; Y Huang; L Kang; H-W Chen; Y-T Chen; Y-R Wee; S-J Chen; B C-M Tan
Journal:  Cell Death Differ       Date:  2014-01-17       Impact factor: 15.828

2.  RNA-editing enzymes ADAR1 and ADAR2 coordinately regulate the editing and expression of Ctn RNA.

Authors:  Aparna Anantharaman; Omid Gholamalamdari; Abid Khan; Je-Hyun Yoon; Michael F Jantsch; Jochen C Hartner; Myriam Gorospe; Supriya G Prasanth; Kannanganattu V Prasanth
Journal:  FEBS Lett       Date:  2017-08-30       Impact factor: 4.124

3.  RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR.

Authors:  Ann M Toth; Zhiqun Li; Roberto Cattaneo; Charles E Samuel
Journal:  J Biol Chem       Date:  2009-08-25       Impact factor: 5.157

4.  MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth.

Authors:  Yael Nemlich; Eyal Greenberg; Rona Ortenberg; Michal J Besser; Iris Barshack; Jasmine Jacob-Hirsch; Elad Jacoby; Eran Eyal; Ludmila Rivkin; Victor G Prieto; Nitin Chakravarti; Lyn M Duncan; David M Kallenberg; Eitan Galun; Dorothy C Bennett; Ninette Amariglio; Menashe Bar-Eli; Jacob Schachter; Gideon Rechavi; Gal Markel
Journal:  J Clin Invest       Date:  2013-06       Impact factor: 14.808

Review 5.  Aicardi-Goutières syndrome: a model disease for systemic autoimmunity.

Authors:  M A Lee-Kirsch; C Wolf; C Günther
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

6.  RNA editing in the human ENCODE RNA-seq data.

Authors:  Eddie Park; Brian Williams; Barbara J Wold; Ali Mortazavi
Journal:  Genome Res       Date:  2012-09       Impact factor: 9.043

7.  A structural determinant required for RNA editing.

Authors:  Nan Tian; Yun Yang; Nora Sachsenmaier; Dominik Muggenhumer; Jingpei Bi; Christina Waldsich; Michael F Jantsch; Yongfeng Jin
Journal:  Nucleic Acids Res       Date:  2011-03-22       Impact factor: 16.971

Review 8.  Examining non-LTR retrotransposons in the context of the evolving primate brain.

Authors:  Sara B Linker; Maria C Marchetto; Iñigo Narvaiza; Ahmet M Denli; Fred H Gage
Journal:  BMC Biol       Date:  2017-08-11       Impact factor: 7.431

9.  ADAR1 is essential for intestinal homeostasis and stem cell maintenance.

Authors:  W Qiu; X Wang; M Buchanan; K He; R Sharma; L Zhang; Q Wang; J Yu
Journal:  Cell Death Dis       Date:  2013-04-18       Impact factor: 9.685

10.  ADAR1 Suppresses Interferon Signaling in Gastric Cancer Cells by MicroRNA-302a-Mediated IRF9/STAT1 Regulation.

Authors:  Lushang Jiang; Min Ji Park; Charles J Cho; Kihak Lee; Min Kyo Jung; Chan Gi Pack; Seung-Jae Myung; Suhwan Chang
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.